Tandem Diabetes Care (NASDAQ:TNDM) Cut to “Neutral” at Citigroup
Citigroup lowered shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) from a buy rating to a neutral rating in a research report released on Tuesday morning, MarketBeat reports. The brokerage currently has $24.00 target price on the medical device company’s stock, down from their prior target price of $35.00. Other research analysts have also […]
Citigroup lowered shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) from a buy rating to a neutral rating in a research report released on Tuesday morning, MarketBeat reports. The brokerage currently has $24.00 target price on the medical device company’s stock, down from their prior target price of $35.00. Other research analysts have also […]
